On August 6, 2013, Robert C. Salisbury informed the Board that he will not stand for re-election when his term as a director expires at the Enzon Pharmaceuticals Inc.'s next annual meeting of stockholders, which is expected to be held by mid-October 2013. Mr. Salisbury's decision not to stand for re-election was not, to the knowledge of the company's executive officers, due to any disagreement with the company on any matter relating to the company's operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.23 USD | +21.45% | +76.92% | +145.73% |
1st Jan change | Capi. | |
---|---|---|
+145.73% | 17.07M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+0.73% | 22.78B | |
-10.77% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- ENZN Stock
- News Enzon Pharmaceuticals, Inc.
- Robert C. Salisbury Not to Stand for Re-Election as Director of Enzon Pharmaceuticals Inc